Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
E3810 (Aciphex) in Refractory Reflux Esophagitis
NCT00770913Phase 3Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Oct 2008
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rabeprazole in reflux esophagitis, sponsored by Eisai Co., Ltd.. Started Oct 2008; status: completed.
02
Drugs
rabeprazole
03
Conditions
reflux esophagitis
Beyond the preview
Go deeper on NCT00770913.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00770913.